These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15844462)

  • 1. [Pulmonary hypertension--classification and treatment: new guidelines].
    Bendayan D; Kramer MR
    Harefuah; 2005 Mar; 144(3):206-10, 229. PubMed ID: 15844462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New international guidelines on pulmonary hypertension].
    Dinh-Xuan AT; Duong-Quy S
    Rev Mal Respir; 2010 Feb; 27(2):110-1. PubMed ID: 20206059
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination pharmacotherapy in the treatment of pulmonary arterial hypertension: continuing education article.
    Tackett KL; Stajich GV
    J Pharm Pract; 2013 Feb; 26(1):18-28. PubMed ID: 23420762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension.
    Murali S
    Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update in basic research in the therapy of pulmonary arterial hypertension].
    Schermuly R; Grimminger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S170-2. PubMed ID: 18814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for pulmonary arterial hypertension.
    Driscoll JA; Chakinala MM
    Expert Opin Pharmacother; 2008 Jan; 9(1):65-81. PubMed ID: 18076339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis-associated pulmonary hypertension: assessment and management.
    Palmero V; Sulica R
    Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of pulmonary arterial hypertension].
    Jaïs X; Bonnet D
    Presse Med; 2010 Jun; 39 Suppl 1():1S22-32. PubMed ID: 20732614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapy of pulmonary hypertension.
    Baumhäkel M; Cremers B; Böhm M
    Herz; 2005 Jun; 30(4):303-10. PubMed ID: 15965807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.